-
AI-ASSISTED QUALITATIVE DATA EXTRACTION AND EVIDENCE MAPPING IN AN UMBRELLA REVIEW
Mar 18, 2026, 21:38 PM -
UNCERTAINTY PROBABILITY THRESHOLDS AND INSUFFICIENT ITERATIONS OF PROBABILISTIC SENSITIVITY ANALYSIS IN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
COST OF CARE AND BUDGET IMPACT OF NOVEL FIRST-LINE (1L) TREATMENTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN COSTA RICA
Mar 18, 2026, 21:38 PM -
SOCIAL AND DEMOGRAPHIC DETERMINANTS OF DISEASE BURDEN AMONG ADULTS WITH SPINAL MUSCULAR ATROPHY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF NOVEL ANDROGEN RECEPTOR INHIBITORS IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: A U.S. ANALYSIS INCORPORATING TWO-WAY SENSITIVITY ASSESSMENT
Mar 18, 2026, 21:38 PM -
TIMING OF ADJUVANT THERAPY AND TOTAL HEALTHCARE EXPENDITURES FOLLOWING ROBOTIC-ASSISTED LOBECTOMY OF NON-SMALL CELL LUNG CANCER: A SEER-MEDICARE ANALYSIS
Mar 18, 2026, 21:38 PM -
POST-HOC VALIDATION OF ROBUST MIXTURE PRIORS FOR BAYESIAN CONTROL ARM AUGMENTATION: A STATISTICAL TEST USING MARGINAL LIKELIHOODS
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS OF FIRSEKIBART FOR THE TREATMENT OF ACUTE GOUT PATIENTS UNSUITABLE FOR STANDARD THERAPY IN CHINA
Mar 18, 2026, 21:38 PM -
EVOLUTION OF FDA COMPANION DIAGNOSTICS
Mar 18, 2026, 21:38 PM -
THEMATIC LITERATURE REVIEW: CMS GENEROUS MODEL - DESIGN, EVIDENCE, AND SAVINGS OUTLOOK
Mar 18, 2026, 21:38 PM -
ECONOMIC ANALYSES OF GENDER-AFFIRMING CARE: A LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH CONCURRENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) THERAPY AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) PRESCRIBED RESMETIROM
Mar 18, 2026, 21:38 PM -
REAL WORLD INSIGHTS INTO OBESITY CARE: UNDERSTANDING TREATMENT PATTERNS AND PAYER COSTS AT AN INTEGRATED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COMPARABILITY OF OPEN AND CLOSED CLAIMS DATA FOR HEALTHCARE RESOURCE UTILIZATION ASSESSMENT IN ACUTE ISCHEMIC STROKE
Mar 18, 2026, 21:38 PM -
AI/ML IN HTA EVIDENCE SYNTHESIS: WHERE DO WE STAND TODAY?
Mar 18, 2026, 21:38 PM -
FACTORS EXPLAINING HPV VACCINE COMPLETION AMONG MEDICAID VACCINE INITIATORS IN KENTUCKY FROM 2010 TO 2022: AN APPLICATION OF GRADIENT BOOSTING
Mar 18, 2026, 21:38 PM -
COST ANALYSIS AND HEALTHCARE RESOURCE UTILIZATION AFTER OPEN LIVER RESECTION FROM A RANDOMIZED CONTROL TRIAL
Mar 18, 2026, 21:38 PM -
AN AUTOMATED SOCIAL MEDIA LISTENING ANALYSIS OF CONVERSATIONS ON CGRP PREVENTIVE THERAPIES IN MIGRAINE
Mar 18, 2026, 21:38 PM -
REAL-WORLD TRENDS AND PAYER DIFFERENCES IN BUPRENORPHINE DISPENSING AMONG ADOLESCENTS AND YOUNG ADULTS (AYA) WITH OPIOID USE DISORDER (OUD)
Mar 18, 2026, 21:38 PM -
ACCELERATING LITERATURE REVIEWS WITH LARGE LANGUAGE MODELS (LLMS): AN EVALUATION OF PERFORMANCE AND EFFICIENCY
Mar 18, 2026, 21:38 PM
